Categories
Market Outlook Market Reports Market Research

Global Home Therapeutic Equipment Market Is Expected to Grow At A CAGR of 9.2% from 2020 to 2027

A paradigm shift has occurred in the home therapeutic equipment market due to a reduction in mortality rate by 19% due to better functional outcomes of patients, monetary savings for home hospice in comparison to huge healthcare burden associated with inpatient hospital settings, etc.

Respiratory therapy equipments are reigning the components segment for the home therapeutic equipment market. A significant increase in minimally invasive surgical procedures and a growing incidence of respiratory diseases together drive the market growth. Rising prevalence of sleep apnea creates an increasing demand for continuous positive airway pressure therapy devices in homecare settings. Dialysis equipment is expected to record rampant market growth in the near future on account of the rising prevalence of chronic kidney diseases worldwide. According to the latest statistics provided by the National Kidney Foundation (NKF), it is estimated that annually 7.1 million people worldwide die with end-stage kidney disease due to a lack of access to dialysis.

Browse the full report Home Therapeutic Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/home-therapeutic-equipment-market

Retail outlets are presently dominating the distribution channel segment for the home therapeutic equipment market. Medical device companies after the manufacturing of medical devices put them for exhibition and sale in their respective retail outlets. Free demonstration of the medical device operating system and availability of various purchasing options promotes its market superiority. E-commerce is keen to highlight comfortable market growth during the forecast period owing to the deep penetration of the internet and access to smartphones by the consumers and sale of therapeutic equipment at affordable prices and opportunities to win attractive discount coupons and gift vouchers.

North America is currently leading the geography segment for the home therapeutic equipment market. The rising prevalence of chronic lifestyle disorders primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 1 in 4 adults are suffering from more than 2 or more chronic disorders. Domicile of key players such as GE Healthcare, Smiths Medical, Becton, Dickinson and Company, Medline Industry, Inc., etc. further propel the market growth in the region. Europe is placed in the 2nd position in the regional segment owing to the nurturing regulatory environment provided by the European Medical Agency (EMA), in the early CE clearance and adoption of medical devices for therapeutic purposes. The Asia Pacific is anticipated to be the fastest-growing regional segment in the home therapeutic equipment market. The emergence of local players creates a hugely competitive market for western giants which provides an assertive impetus on the home therapeutic equipment market growth in the region.

Medical device manufacturers actively engaged in the production of home therapeutic equipment are GE Healthcare, Drägerwerk AG & Co., Medtronic, Plc., Fresenius Kabi AG, Nipro Corporation, Philips Healthcare, Smiths Medical, Novo Nordisk A/S, Becton, Dickinson and Company and Medline Industry, Inc.

Key Market Movements:

  • Rising prevalence of lifestyle chronic diseases worldwide
  • Technological advancement in the medical devices associated with homecare settings to propel the market growth
  • Nurturing regulatory environment by the healthcare agencies by providing early CE clearance and adoption of medical devices for therapeutic purposes

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global High Definition Breast Tomosynthesis Market is expected to grow at a CAGR of 13.5% from 2020 to 2027

Breast tissues attain different morphology at different stages of life primarily influenced by the hormonal levels and environmental factors affecting the human body. High definition tomosynthesis is an up-gradation to the earlier versions of digital breast tomosynthesis which is useful in achieving high-resolution images and videos of breast cancer cells and tissue under investigation. Breast tomosynthesis employs a low radiation dose by employing an x-ray tube that moves like an arc achieving breast images from different angles to create multiple data points that can be reconstructed in different ways for effective diagnosis of breast cancer cases.

2D/3D combination systems are presently leading the product segment for high definition breast tomosynthesis market. The major factor responsible for its technical viability among oncologists is its capability to precisely analyze the calcification and no calcification cases of breast cancer which is relatively difficult to analyze by employing either dimensional system. Standalone 3D systems are very crucial in screening breast cancer owing to its excellent ergonomic features such as increased sensitivity and reduced recalls rendering it to effectively diagnose invasive cancer cases and reduction in false-positive cases.

Browse the full report High Definition Breast Tomosynthesis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/high-definition-breast-tomosynthesis-market

Hospitals are dominating the end-user segment for the high definition breast tomosynthesis market. The primary health care centers are the first point of contact for patients opting for early screening of breast cancer. Government health agencies are providing huge funds for the establishment of well-equipped devices for performing screening of breast cancer. Diagnostic centers have gained tremendous traction in the last decade on account of the availability of a skilled workforce for the operating of sophisticated breast tomosynthesis devices and precise interpretation of images.

North America is holding the largest market share in the geography segment for high definition breast tomosynthesis market. As per the research citings brought forward by the American Cancer Society (ACS) in 2019 in the United States approximately 268,600 new cases of breast cancer were reported among the women population. Existence of key players such as Hologic, Inc., GE Healthcare, Siemens Healthineers further propel the market growth pertaining to high definition breast tomosynthesis in the region. In Europe the number of breast cancer cases among the female population as diagnosed in 2018 was 562,500 according to the statistics of the European Breast Cancer Coalition. The strategic collaboration between academic research institutes and medical device manufacturers for the development of breast tomosynthesis devices. Asia Pacific is set to register impressive growth during the forecast period owing to the increasing public health awareness related to the benefits of early screening in breast cancer and developing healthcare infrastructure.

Medical device manufacturers pioneering in the production of high definition breast tomosynthesis are Siemens Healthineers, GE Healthcare, Fujifilm Corporation, Hologic, Inc., Agfa-Gevaert, IMS GIOTTO S.p.A., PLANMED OY., Dexela Ltd., Carestream Health and Metaltronica S.p.A.

Market Key Takeaways:

  • Rising prevalence of breast cancer worldwide
  • Technological advancement and up gradation in the breast tomosynthesis devices to achieve high-resolution images
  • Strategic collaboration between academic research institutes and medical device manufactures to develop high definition breast tomosynthesis devices

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Dietary Fiber Nutritional Supplements Market is expected to grow at a CAGR of 12.6% from 2020 to 2027

Nutritional science has undergone tremendous technical development in the last 5 decades eventually resulting in effective extraction from natural sources such as cereals, grains, fruits, and vegetables. Rising prevalence of gastrointestinal disorders, growing inclination for the consumption of unhealthy junk food, and sedentary lifestyle determines the dietary fiber nutritional supplements market growth. Proactive marketing of dietary fibers on social media will further accentuate the dietary fibers market growth in the near future.

The soluble dietary fibers are spearheading the type segment for dietary fiber nutritional supplements market. It is further sub-segmented as pectin, inulin, polydextrose, beta-glucan, etc. It usually forms a viscous gel-like substance when it comes in contact with the digestive fluid. It usually delays the digestion rate thereby reduces the feeling of hunger and food intake and is capable of maintaining a healthy weight. It has the ability to sequester blood cholesterol and is helpful in regulating blood glucose levels. It has been crucial in preventing the disease manifestation of chronic diseases such as cardiovascular disease and type 2 disease. Insoluble dietary fibers are gaining tremendous importance in their ability to maintain healthy gut flora and regulation of a peristaltic activity which is beneficial in treating chronic constipation.

Browse the full report Dietary Fiber Nutritional Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dietary-fiber-nutritional-supplements-market

The supermarket is reigning the distribution channel segment in the dietary fiber nutritional supplements market. The chief contributing factors responsible for its market dominance are its inherent features such as lower operation and overhead cost and location in the central place of the city which attracts a huge customer base. It has the ability to display dietary fibers from several manufacturers and endorsed by different brands at competitive prices. E-commerce has gained tremendous traction in the last decade on account of a significant rise in the population using smartphones at the ability to reach a huge customer base with dietary fiber products at attractive discount rates.

North America is dominating the geography segment for the dietary fiber nutritional supplements market. The rising prevalence of the geriatric population suffering from gastrointestinal disorder primarily drives the market growth. Domicile of key players such as Archer Daniels Midland Company, BENEO, Cargill Corporation, DuPont, etc. further fortifies the dietary fiber nutritional supplements market in the region. Europe is in the 2nd place on account of the rising public health awareness regarding the useful application of insoluble fibers in achieving healthy gut microflora and peristaltic activity. The Asia Pacific is expected to register rampant market growth in the near future on account of the flourishing e-commerce segment which is providing a diverse range of dietary fiber products at affordable prices and attractive coupons.

Pharmaceutical companies manufacturing dietary fiber nutritional supplements are Archer Daniels Midland Company, Royal DSM, Citrucel, Robinson Pharma, Inc., BENEO, Cargill Corporation, Tate & Lyle, Plc., Viachem, Meron Group, and DuPont.

Market Key Takeaways:

  • Rising prevalence of gastrointestinal disorders in the elderly population worldwide
  • Increasing public health awareness regarding the useful application of prebiotics in maintaining healthy gut microflora and motility
  • Flourishing e-commerce segment providing a diverse range of dietary fibers at affordable prices and attractive coupons

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]esearch.com

Categories
Market Outlook Market Reports Market Research

Global Amoxicillin Sodium Market Is Expected to Grow At A CAGR of 3.0% from 2020 to 2027

Amoxicillin sodium is considered as a broad-spectrum antibiotic having potent bactericidal activity. It exerts its pharmacological activity by binding to and inactivating the penicillin-binding proteins which are located in the inner membrane of the bacterial cell wall. It is enlisted in the World Health Organization (WHO) list of essential medicines.

Respiratory infections are reigning the clinical application segment for the amoxicillin sodium market. As per the latest information provided by the World Bank data in 2017, pneumonia is responsible for 15% of all the deaths occurring in children below 5 years of age worldwide. It is considered as first-line drug therapy for the treatment of lower respiratory tract infection. It is either used alone or in combination with potassium clavulanate for the treatment of ear and skin infections throughout the globe. Urinary tract infection is expected to record comfortable market growth during the forecast period owing to the rising prevalence of urinary tract infection caused due to E.coli infection. According to the recent research citings provided by the World Health Organization (WHO), the prevalence rate of community-associated urinary tract infection is 0.7% across the globe.

Browse the full report Amoxicillin Sodium Market  – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/amoxicillin-sodium-market

Hospital pharmacy is currently spearheading the distribution channel segment for the amoxicillin sodium market. The drug is a broad-spectrum antibiotics with different drug posology for different infections, hence precise drug compounding is mandatory to prevent the occurrence of any unwanted side effects. Retail pharmacy is keen to register rampant market growth in the near future on account of the availability of government-subsidized medicines at low prices and serves the medicinal requirements of people residing in remote locations.

North America is presently leading the geography segment for the amoxicillin sodium market. The rising prevalence of urinary tract infections primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 40% of the women population in the United States is suffering from urinary tract infection annually. Furthermore, the domicile of key players such as Merck KGaA., Denton Pharma, Inc., Teva Pharmaceutical Industries Ltd., etc further propels the market growth. Europe is placed 2nd in the regional segment on account of the Nurturing regulatory environment provided by the European Medical Agency (EMA) of the rising prevalence of respiratory tract infections and affordable reimbursement scenario for the amoxicillin sodium drug products in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the amoxicillin sodium market. Flourishing generic drugs market and the emergence of local players together accentuate the market growth in the region.

Pharmaceutical manufacturers actively engaged in the production of amoxicillin sodium are Merck KGaA, Denton Pharma, Inc., Sandoz, Inc., Teva Pharmaceutical Industries Ltd., Wockhardt UK Ltd., Aurobindo Pharma Ltd., Alkem Labs., Mylan Pharmaceutical Industries Ltd., GlaxoSmithKline, Plc., and Sun Pharmaceutical Industries Ltd.

Key Market Movements:

  • A constant rise in the number of patients suffering from lower respiratory tract infections worldwide
  • Rising prevalence of urinary tract infection throughout the globe
  • Supportive regulatory environment provided by the healthcare agencies for the sale and use of amoxicillin sodium products

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Serotonin Supplements Market Is Expected to Grow At A CAGR of 7.7% from 2020 to 2027

Serotonin supplements that boost the natural production of serotonin in the human body are 5-hydroxytryptophan, tryptophan, s-adenosyl methionine, pyridoxine, folic acid, L-theanine, Rhodiola Rosea, Garcinia cambogia, etc. Rising public health awareness regarding the therapeutic efficacy of serotonin supplements in treating mental disorders and insomnia drives the market growth.

Anxiety and mood disorders are spearheading the clinical application segment for the serotonin supplements market. According to the latest statistics provided by the World Bank data in 2017, approximately 284 million people worldwide were reported to be suffering from an anxiety disorder. Further clinical research studies suggest that the prevalence rate of anxiety is 2.8% in males and 4.7% in females respectively. Mood disorder will be showcasing exemplary growth in the young population throughout the globe due to the consumption of alcohol, tobacco, ecstasy substances, stress, poor social life, etc. Insomnia will be highlighting steady market growth in the near future owing to the rising consumption of caffeinated products and psychological factors affecting mental health.

Browse the full report Serotonin Supplements Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/serotonin-supplements-market

Hypermarkets are currently dominating the distribution channel segment for the serotonin channel segments market. It serves as a lucrative market opportunity for consumers who believe in a one-stop shopping destination getting exposure to diverse product portfolios for serotonin supplements at affordable prices. Retail stores are considered as the most viable shopping option for consumers receiving a physician’s prescription for dietary supplements. E-commerce is expected to record excellent market growth during the forecast period owing to the adoption of smartphones by large consumer base worldwide and attractive discount coupons awarded on the purchase of dietary supplements and medicines on regular basis.

North America is presently leading the geography segment for the serotonin supplements market. The growing incidence of insomnia in the elderly population primarily drives the market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 1 in 4 American citizen develops insomnia each year. Domicile of key players such as Jarrow Formulas, Arazo Nutrition, Natrol, Swanson, etc. will further accentuate the market growth in the region. Europe is placed in the 2nd position in the regional segment owing to the rising prevalence of anxiety in the younger population. As per the latest information provided by the World Health Organization (WHO), each year approximately 25% population suffers from anxiety in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the serotonin supplements market. Flourishing traditional and herbal medicines enriched in 5HTP and tryptophan will steer the serotonin supplements market growth in the region.

Nutraceutical manufacturers actively engaged in the production of serotonin supplements are Jarrow Formulas, Arazo Nutrition, Natrol (Aurobindo Pharma USA, Inc.), Source Naturals, Solgar (Nature’s Bounty Co), Holland & Barrett (LetterOne), Swanson, The Genius Brand, Pure Encapsulation, Inc. (Nestle S.A.) and Scripts of Nature.

Key Market Movements:

  • Rising prevalence of anxiety and mood disorders worldwide
  • A constant rise in the number of elderly people suffering from insomnia throughout the globe
  • Rising public health awareness regarding the therapeutic efficacy of serotonin supplements in treating mental disorders and insomnia

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Dried Aluminium Hydroxide Gels Market Is Expected to Grow At A CAGR of 3.6% from 2020 to 2027

Dried aluminium hydroxide gel is also known as aluminium hydroxide gel, which is currently available as a generic drug and over the counter product in the various distribution channel. Citrate enriched food intake must be prevented while consuming aluminium hydroxide gel as it promotes excessive absorption of aluminium which is fatally toxic.

An antacid is presently reigning the clinical application segment for dried aluminium hydroxide gels market. The drug is a popular acid-neutralizing agent which is used in combination with other chemical moieties such as magnesium hydroxide and dimethicone for neutralizing excess hydrochloric acid present in the stomach environment. The dosage as an antacid for oral intake is liquid 320mg/5ml is 5 to 15 ml after every 6 hours. Hyperphosphatemia is expected to grow at a rampant pace owing to the growing incidence of hyperphosphatemia in patients suffering from chronic kidney diseases. The serum level of phosphorus is greater than 7mg/dl then use dried aluminium hydroxide gel for 4 to 6 weeks only depending on the dialysis clearance of phosphorus as the mean phosphorus binding is 22.3mg of phosphorus/5ml of aluminium hydroxide.

Browse the full report Dried Aluminium Hydroxide Gels Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/dried-aluminium-hydroxide-gels-market

Hospital pharmacy is currently leading the distribution channel segment for dried aluminium hydroxide gels market. Severe constipation, rash and nausea are the major side effects associated with dried aluminium hydroxide gel hence accurate dispensing by hospital pharmacist is imperative for patients suffering from acidity and heartburns. Retail pharmacy is keen to record impressive market growth owing to the constant surge observed in the over the counter (OTC) products and generic drugs market in the developing regions.

North America is presently dominating the geography segment for dried aluminium hydroxide gels market. Growing incidence of gastric indigestion primarily drives the market growth in the region. As per the latest statistics provided by the American College of Gastroenterology (ACG), approximately 60 million American complain about heartburn at least once a month. The supportive regulatory environment provided by the USFDA for the sale and distribution of dried aluminium gel products and affordable reimbursement scenario for the dried aluminium hydroxide gels drugs formulation together fortifies the market growth in the region. Europe is the second-largest regional segment on account of the effective collaboration between research academia and pharmaceutical companies to understand the therapeutic efficacy of dried aluminium hydroxide gel in the treatment of hyperphosphatemia in patients suffering from renal disease. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period on account of flourishing over the counter (OTC) products market and the emergence of local players.

Pharmaceutical manufacturers actively engaged in the production of dried aluminium hydroxide gels are Kyowa Chemical Industry, SPI Pharma, Walgreen Company, Merck KGaA, Sanofi-Aventis, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Mylan Seiyaku and Sun Pharmaceuticals Ltd.

Key Market Movements:

  • Rising prevalence of gastric acidity worldwide
  • Significant increase in the number of hyperphosphatemia cases recorded worldwide in patients suffering from chronic kidney diseases
  • Affordable reimbursement scenario and availability of affordable over the counter products of dried aluminium hydroxide gel together bolster the market growth

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Wolfberry Extracts Market Is Expected to Grow At A CAGR of 8.7% from 2020 to 2027

Wolfberry extracts are also known as the Lycium barbarum is an indigenous evergreen shrub of the South Asian region being used as a traditional herbal medicine for centuries. They are rich in nutrients and provides vitamin B, manganese, copper, magnesium, and selenium, being a red-colored fruit it contains a sufficient quantity of carotenoids and zeaxanthin.

Immunity booster is reigning the clinical application segment for wolfberry extracts market. According to the latest information provided by the National Institute of Health (NIH), annually approximately 200 000 deaths are reported associated with lower respiratory tract infections associate with influenza. The serious threat imposed by the RNA viral infections worldwide and the looming threat of hospital-acquired infections creates a burgeoning requirement of immunity booster in people across all age groups throughout the globe. Dietary supplements are going to register rampant market growth in the near future owing to increasing demand for wolfberry extract in the management of chronic lifestyle disorders such as hypertension and diabetes.

Browse the full report Wolfberry Extracts Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/wolfberry-extracts-market

A supermarket is currently dominating the distribution channel segment for wolfberry extracts market. Capacity to showcase diverse product portfolio pertaining to herbal medicines and the ability to cater to a large consumer base opting for a one-stop shopping destination primarily drives the market growth. Retail stores are gaining huge traction on account of its ability to provide dietary supplements to consumers residing in remote locations. E-commerce is keen to register exemplary market performance due to deep internet penetration, access to smartphones, and attractive discounts awarded on the purchase of dietary supplements.

North America is presently leading the geography segment for wolfberry extracts market. The growing incidence of influenza across all age groups primarily drives the market growth in the region. According to the latest statistics provided by the Center for Disease Control and Prevention (CDC), the death rate associate with seasonal flu is 0.1% in the United States. Additionally, the presence of large disposable income and increasing public health awareness regarding the diverse health benefits of wolfberry extracts drive the market growth in the region. Europe is the second-largest regional segment in the regional segment owing to the nurturing regulatory environment provided by the European Medical Agency (EMA) for the sale and marketing of herbal medicines in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for wolfberry extracts market. Flourishing E-commerce industry and proactive role adopted by government healthcare agencies to revitalize traditional and herbal medicines in the Asia Pacific region.

Nutraceutical manufacturers actively engaged in the production of wolfberry extracts are Swanson Health Products, Piping Rock Health Products, Navitas Naturals, Ayurish, Natierra, Shaanxi NHK Technology Co., Ltd., Ningxia Red-Goji Berry Trade Co., Ltd., Bolise Co., Limited, Parchem and Botanical Cube, Inc.

Key Market Movements:

  • Significant increase in the number of infectious diseases reported in immunocompromised patients worldwide
  • Rising public health awareness regarding the diverse health benefits associated with wolfberry extract as a dietary supplement
  • Proactive role adopted by government authorities in the South Asia countries to revitalize traditional and herbal medicines

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Escitalopram Market is expected to grow at a CAGR of 2.9% from 2020 to 2027

Escitalopram is frequently prescribed by psychiatrists throughout the globe for the treatment of mental illness such as major depressive disorders, generalized anxiety disorders, post-traumatic stress disorders, etc. Least side effect profile, high tolerability, and minimum damage caused to the hepatic cytochrome enzymes have made a highly popular drug in treating mental disorders and are recorded in the World Health Organization (WHO) essential medicines list.

Major depression disorders are leading the diseased segment for the Escitalopram market. According to the statistics brought forward by the World Health Organization (WHO), approximately more than 300 million people worldwide are reported to be suffering from a major depressive disorder. The primary factors responsible for its huge epidemiological data are errant sleeping patterns, frequent mood swings, and money-related stress. The disease is highly manifested in the developing nations owing to the deteriorating socio-economic conditions which have a negative impact on the individual’s health. PTSD is expected to register faster growth on account of the significant rise of overwhelming guilt, anti-social lifestyle, and self-destructive behavior frequently encountered among the younger population worldwide.

Browse the full report Escitalopram Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/escitalopram-market

Hospital pharmacy is spearheading the end-user segment for the Escitalopram market. The primary features associated with hospital pharmacy mode of operations such as individual medicine order system, unit dose system, and automatic medicine dispensing, are essential requirements associated with medicines prescribed for neuropsychiatric illness. Retail pharmacies have gained tremendous growth momentum in the last decade owing to its ability to store bulk stock of generic version of Escitalopram and potential to cater to medicine requirements of patients residing in remote locations.

In the current situation, North America is leading the geography segment for the Escitalopram market. As per the research citings of the World Health Organization the prevalence rate of post-traumatic stress disorder in the United States is 6.8%. According to the National Institute of Health (NIH) each year approximately 25.3 million prescriptions of Escitalopram are sold in the United States. Effective implementation of treatment Guidelines pertaining to mental health further consolidated the market growth in the region. The prevalence rate of PTSD in Europe is 1.9% and is anticipated to rise in the younger population owing to the antisocial lifestyle and a significant increase in insomnia. Furthermore, an affordable reimbursement scenario determines the market growth in the region. The Asia Pacific is set to record steady growth during the forecast period on account of the rising prevalence of generalized anxiety depression among the middle-aged population and availability of a generic version of Escitalopram at a relatively lower cost.

Pharmaceutical companies actively engaged in the manufacturing of Escitalopram dosage forms are H. Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Macleods Pharmaceuticals, Jubilant Cadista, Teva Pharmaceutical Company Limited, Pharmacare, Plc., Lupin Pharmaceuticals, Prinston Pharmaceuticals, Inc. and Invagen Pharma.

Market Key Takeaways:

  • Rising prevalence of mental disorders such as major depressive disorder and post-traumatic stress disorder
  • Affordability reimbursement scenario for Escitalopram dosage forms
  • The availability of relatively low-cost generic versions and improved pharmacodynamics properties increases its popularity as a prescription drug for treating mental illness.

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Deferiprone Market is expected to grow at a CAGR of 1.4% from 2020 to 2027

Deferiprone is an iron-chelating agent used in the treatment of iron overload associated with blood transfusion and non-transfusion-dependent thalassemia (NTDT). It is available as 500mg & 1000 mg film-coated tablets and 100mg/ml oral solution, which needs to be taken only under medical supervision to negate any possible outcome of drug-related adverse events.

Transfusional iron overload is currently reigning the indication segment for the deferiprone market. The human body does not possess any active mechanism for the excretion of iron, which is eventually excreted via sweat, menstruation, and excretion of enterocytes. It is an understood fact that a single unit of blood transfusion comprises of 250mg of iron. A significant increase in the number of patients suffering from blood-related disorders requiring frequent blood transfusion such as thalassemia, sickle cell anemia, hemolytic anemia, etc., causes the deposition of excess iron in various human body parts. Non-Transfusion-Dependent Thalassemia (NTDT) caused iron overload is keen to grow at a rampant market growth on account of the significant increase in the genetic disorder associated with NTDT such as beta-thalassemia intermedia, hemoglobin H disease, E beta-thalassemia, etc. throughout the globe. Poor erythropoiesis and excellent hemolysis cause a huge deposition of iron concentration in the liver cells.

Browse the full report Deferiprone Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/deferiprone-market

Hospital pharmacy is spearheading the distribution channel segment for the deferiprone market. Deferiprone is possessing severe drug-related adverse effects such as abdominal pain, vomiting, backache, headache, etc., it is necessary to be dispensed by a hospital pharmacist with precise drug posology in accordance to doctor’s prescription in the developed regions. The retail pharmacy will be the fastest-growing distribution channel segment during the forecast period on account of its ability to provide different compositions of deferiprone as generic medicine at competitive prices which benefits poor customers.

North America is presently holding the largest market share in the geography segment for the deferiprone market. According to the latest information provided by the Center for Disease Control and Prevention (CDC), in North America, the prevalence of Beta thalassemia is approximately 1 per 100, 000 people. Additionally, a large influx of immigrants from around the globe to North America in the last 2 decades has significantly increased the number of individuals suffering from transfusional iron overload associated with blood-related disorders which further accelerates the deferiprone market growth in the region. The presence of a well-developed healthcare infrastructure further accentuates its market growth. The market growth in the European region is primarily driven by the supportive regulatory environment provided by the European Medical Agency for the sale and distribution of deferiprone drugs in the region. Furthermore, an affordable reimbursement scenario for deferiprone as an iron-chelating agent for treating hemoglobin and thalassemia disorders further propels the market growth in the region. The Asia Pacific is set to register rapid market growth in the near future on account of the rising prevalence of Beta-thalassemia in South East Asia and the establishment of the highly competitive generic drugs market.

Pharmaceutical companies actively engaged in the manufacturing of deferiprone drug formulation are ApoPharma USA, Inc., Chiesi Canada Corp., Apotex Europe BV, Cipla Limited, Focus Pharmaceuticals Limited, Genepharm S.A., Lipomed AG., Evolan Pharma AB, Swedish Orphan Biovitrum AB. and Taro Pharmaceuticals U.S.A., Inc.

Market Key Takeaways:

  • Significant increase in the number of patients suffering from beta-thalassemia worldwide
  • Rising prevalence of blood-related disorders requiring frequent blood transfusion often resulting in iron overload
  • Affordable reimbursement scenario for deferiprone used as a chelating agent in transfusion iron overload and NTDT caused an iron overload

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Categories
Market Outlook Market Reports Market Research

Global Imidazole Buffer Market Is Expected to Grow at a CAGR of 7.3% from 2020 to 2027

Imidazole is very popular in the biopharmaceutical industry and is frequently used as a buffer for pH ranging from 6.2-7.8 at 25°C. Imidazole buffer is used in several biochemical enzymatic reactions and finds immense application in the detection of proteins by the reverse staining of SDS-PAGE gels.

High throughput screening is currently dominating the application segment for the imidazole buffer market. It is widely employed in medicinal chemistry to identify the best stereoisomer of a chemical entity that has an excellent pharmacodynamic and pharmacokinetic drug profile. Optimization of biomolecules is the need of the hour owing to the high mortality rate associated with RNA viral infections such as coronavirus, ebola, swine flu, etc. In the current scenario, there is only a limited number of medicines available in the market which provides only symptomatic relief to such RNA viral infections and has no benefit in patients having compromised immune systems.

Browse the full report Imidazole Buffer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/imidazole-buffer-market

The biopharmaceutical industry is spearheading the end-user segment for the imidazole buffer market. The looming threat of antimicrobial resistance and constantly increasing viral infection worldwide together drive the Biopharmaceutical industry market growth. Research academia is expected to grow at a steady market growth on account of the huge funding provided by the government healthcare agencies for the novel drug development for the treatment of lifestyle disorders such as cardiovascular, pulmonary, and autoimmune diseases.

North America is currently leading the geography segment for the imidazole buffer market. The chief parameters associated with superior market growth is the establishment of a well-developed life sciences industry actively engaged in providing medical aid to the people of North America. The government healthcare agency such as the National Institute of Health (NIH), is collaborating with the academic research institutes to conduct research and development associated with the development of new biomolecules for curbing the mortality associated with chronic diseases. Furthermore, the presence of major players such as Merck KGaA, AAT Bioquest, Inc., Boston Bioproducts, Santa Cruz Biotechnology, Inc., etc further bolsters the imidazole buffer market growth in the region. Europe is in the 2nd place in the regional segment for the imidazole buffer market owing to the strategic partnership between the academic research institutes and biopharmaceutical companies actively engaged in conducting preclinical trials of new drug entities. Asia Pacific is anticipated to be the fastest-growing regional segment for the imidazole buffer market owing to the rising prevalence of infectious disease and competitive environment created by the western giants to the local players engaged in the manufacturing of imidazole buffers and other chemical reagents.

Chemical reagent manufacturers actively engaged in the production of imidazole buffers are Merck KGaA., AAT Bioquest, Inc., Hampton Research, HYPHEN BioMed (Sysmex Group Company), Boston Bioproducts, Diapharma Group, Hart Biologicals, Cryopep, VWR International, LLC. (Avantor) and Santa Cruz Biotechnology, Inc.

Market Key Takeaway:

  • Significant increase in the number of people suffering from infectious and chronic disease worldwide
  • Increasing throughput screening activities conducted to negate the drug-related side effects
  • Huge funding provided by the government healthcare agencies for conducting the preclinical trials associated with the investigation of a new drug molecule

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]